Jennifer Mclachlan
203 Fulham Road
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Real-World Outcomes of Immunotherapy for Melanoma Brain Metastases in New Zealand.
Journal: JCO oncology practice
Published: July 25, 2024
Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK - A16037).
Journal: Therapeutic advances in medical oncology
Published: May 14, 2020
Low-grade serous ovarian carcinoma: A comprehensive literature review.
Journal: The Australian & New Zealand journal of obstetrics & gynaecology
Published: June 19, 2019
Trends in the overall survival rates in women with advanced ovarian cancer in a single tertiary centre in New Zealand.
Journal: The Australian & New Zealand journal of obstetrics & gynaecology
Published: February 07, 2019
The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole.
Journal: BMC cancer
Published: February 01, 2017
The current status of PARP inhibitors in ovarian cancer.
Journal: Tumori
Published: September 01, 2016
Targeting the mitogen-activated protein kinase pathway in low-grade serous carcinoma of the ovary.
Journal: Pharmacogenomics
Published: July 30, 2016
Olaparib for the treatment of epithelial ovarian cancer.
Journal: Expert opinion on pharmacotherapy
Published: March 12, 2016
Targeted agents and combinations in ovarian cancer: where are we now?
Journal: Expert review of anticancer therapy
Published: March 05, 2016
Bleomycin-Induced Flagellate Erythema in a Patient Diagnosed with Ovarian Yolk Sac Tumor.
Journal: Case reports in oncological medicine
Published: October 07, 2015
Last Updated: 09/26/2026